These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 9022602
1. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors. Wilcox JG, Hatch IE, Gentzschein E, Stanczyk FZ, Lobo RA. Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602 [Abstract] [Full Text] [Related]
2. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Chu MC, Cosper P, Nakhuda GS, Lobo RA. Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346 [Abstract] [Full Text] [Related]
3. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women. Carr BR, Khan N, Adams-Huet B, Kakarla N, Havelock JC, Gell J. Fertil Steril; 2006 Mar; 85(3):667-73. PubMed ID: 16500336 [Abstract] [Full Text] [Related]
4. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women]. Lai A, Zhang J, Ding L. Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165 [Abstract] [Full Text] [Related]
8. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension. Modena MG, Rossi R, Muia N, Origliani G, Rombolà O, Molinari R. G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776 [Abstract] [Full Text] [Related]
10. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B, Guzic-Salobir B, Sebestjen M, Keber I. Menopause; 2006 Jun; 13(4):643-50. PubMed ID: 16837886 [Abstract] [Full Text] [Related]
13. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women. Post MS, Christella M, Thomassen LG, van der Mooren MJ, van Baal WM, Rosing J, Kenemans P, Stehouwer CD. Arterioscler Thromb Vasc Biol; 2003 Jun 01; 23(6):1116-21. PubMed ID: 12730085 [Abstract] [Full Text] [Related]
14. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H. Thromb Haemost; 2001 Apr 01; 85(4):619-25. PubMed ID: 11341495 [Abstract] [Full Text] [Related]
15. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Maffei S, Del Ry S, Prontera C, Clerico A. Clin Sci (Lond); 2001 Nov 01; 101(5):447-53. PubMed ID: 11672449 [Abstract] [Full Text] [Related]